CAT/CLAMS: Its use in detecting early childhood cognitive impairment

David A. Kube; William M. Wilson; Mario C. Petersen; Frederick B. Palmer

doi:10.1016/S0887-8994(00)00191-0

CAT/CLAMS: Its use in detecting early childhood cognitive impairment

David A. Kube, William M. Wilson, Mario C. Petersen, Frederick B. Palmer

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

The Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS), a neurodevelopmental tool for the cognitive assessment of infants and toddlers, correlates well with the Bayley Scales of Infant Development. In 1993 the Bayley Scales were revised and the second edition published (BSID-II). This study was designed to determine how well the CAT/CLAMS correlates with the BSID-II and its utility in identifying mild and severe cognitive impairment. Sixty-eight infants and toddlers (age range = 14-48 months), referred for suspected developmental delays, were administered the CAT/CLAMS and BSID-II and the results compared. The correlation between the two instruments was strong (r = 0.89, P < 0.0001). The CAT/CLAMS was sensitive (81%) and specific (85%) for detecting overall cognitive impairment (BSID-II less than 70) and was even more sensitive (100%) and specific (96%) in detecting severe cognitive impairment (BSID-II less than 50). The physician using the CAT/CLAMS formulated a clinical impression of cognitive impairment that was sensitive (95%) and specific (84%) compared with formal psychologic testing. The CAT/CLAMS correlates well with the BSID-II. It is useful for detecting and quantifying mild and severe cognitive impairment. It permits the physician to formulate an accurate clinical impression of cognitive impairment consistent with possible mental retardation. (C) 2000 by Elsevier Science Inc.

Original language	English (US)
Pages (from-to)	208-215
Number of pages	8
Journal	Pediatric Neurology
Volume	23
Issue number	3
DOIs	https://doi.org/10.1016/S0887-8994(00)00191-0
State	Published - Sep 2000
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Neurology
Developmental Neuroscience
Clinical Neurology

Access to Document

10.1016/S0887-8994(00)00191-0

Cite this

@article{30c59e9dbc714623a5773b2f6fa8f481,

title = "CAT/CLAMS: Its use in detecting early childhood cognitive impairment",

abstract = "The Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS), a neurodevelopmental tool for the cognitive assessment of infants and toddlers, correlates well with the Bayley Scales of Infant Development. In 1993 the Bayley Scales were revised and the second edition published (BSID-II). This study was designed to determine how well the CAT/CLAMS correlates with the BSID-II and its utility in identifying mild and severe cognitive impairment. Sixty-eight infants and toddlers (age range = 14-48 months), referred for suspected developmental delays, were administered the CAT/CLAMS and BSID-II and the results compared. The correlation between the two instruments was strong (r = 0.89, P < 0.0001). The CAT/CLAMS was sensitive (81%) and specific (85%) for detecting overall cognitive impairment (BSID-II less than 70) and was even more sensitive (100%) and specific (96%) in detecting severe cognitive impairment (BSID-II less than 50). The physician using the CAT/CLAMS formulated a clinical impression of cognitive impairment that was sensitive (95%) and specific (84%) compared with formal psychologic testing. The CAT/CLAMS correlates well with the BSID-II. It is useful for detecting and quantifying mild and severe cognitive impairment. It permits the physician to formulate an accurate clinical impression of cognitive impairment consistent with possible mental retardation. (C) 2000 by Elsevier Science Inc.",

author = "Kube, {David A.} and Wilson, {William M.} and Petersen, {Mario C.} and Palmer, {Frederick B.}",

note = "Funding Information: This study was supported in part by grant 90-DD-0504-02 from the U.S. Department of Health and Human Services, Administration for Children and Families, and by USPHS grant MC-00038-09 from the Health Resources and Services Administration{\textquoteright}s Maternal and Child Health Bureau. This work was presented in part at the 1998 Annual Meeting of the Pediatric Academic Societies, New Orleans, LA, May 3, 1998. ",

year = "2000",

month = sep,

doi = "10.1016/S0887-8994(00)00191-0",

language = "English (US)",

volume = "23",

pages = "208--215",

journal = "Pediatric Neurology",

issn = "0887-8994",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - CAT/CLAMS

T2 - Its use in detecting early childhood cognitive impairment

AU - Kube, David A.

AU - Wilson, William M.

AU - Petersen, Mario C.

AU - Palmer, Frederick B.

N1 - Funding Information: This study was supported in part by grant 90-DD-0504-02 from the U.S. Department of Health and Human Services, Administration for Children and Families, and by USPHS grant MC-00038-09 from the Health Resources and Services Administration’s Maternal and Child Health Bureau. This work was presented in part at the 1998 Annual Meeting of the Pediatric Academic Societies, New Orleans, LA, May 3, 1998.

PY - 2000/9

Y1 - 2000/9

N2 - The Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS), a neurodevelopmental tool for the cognitive assessment of infants and toddlers, correlates well with the Bayley Scales of Infant Development. In 1993 the Bayley Scales were revised and the second edition published (BSID-II). This study was designed to determine how well the CAT/CLAMS correlates with the BSID-II and its utility in identifying mild and severe cognitive impairment. Sixty-eight infants and toddlers (age range = 14-48 months), referred for suspected developmental delays, were administered the CAT/CLAMS and BSID-II and the results compared. The correlation between the two instruments was strong (r = 0.89, P < 0.0001). The CAT/CLAMS was sensitive (81%) and specific (85%) for detecting overall cognitive impairment (BSID-II less than 70) and was even more sensitive (100%) and specific (96%) in detecting severe cognitive impairment (BSID-II less than 50). The physician using the CAT/CLAMS formulated a clinical impression of cognitive impairment that was sensitive (95%) and specific (84%) compared with formal psychologic testing. The CAT/CLAMS correlates well with the BSID-II. It is useful for detecting and quantifying mild and severe cognitive impairment. It permits the physician to formulate an accurate clinical impression of cognitive impairment consistent with possible mental retardation. (C) 2000 by Elsevier Science Inc.

AB - The Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS), a neurodevelopmental tool for the cognitive assessment of infants and toddlers, correlates well with the Bayley Scales of Infant Development. In 1993 the Bayley Scales were revised and the second edition published (BSID-II). This study was designed to determine how well the CAT/CLAMS correlates with the BSID-II and its utility in identifying mild and severe cognitive impairment. Sixty-eight infants and toddlers (age range = 14-48 months), referred for suspected developmental delays, were administered the CAT/CLAMS and BSID-II and the results compared. The correlation between the two instruments was strong (r = 0.89, P < 0.0001). The CAT/CLAMS was sensitive (81%) and specific (85%) for detecting overall cognitive impairment (BSID-II less than 70) and was even more sensitive (100%) and specific (96%) in detecting severe cognitive impairment (BSID-II less than 50). The physician using the CAT/CLAMS formulated a clinical impression of cognitive impairment that was sensitive (95%) and specific (84%) compared with formal psychologic testing. The CAT/CLAMS correlates well with the BSID-II. It is useful for detecting and quantifying mild and severe cognitive impairment. It permits the physician to formulate an accurate clinical impression of cognitive impairment consistent with possible mental retardation. (C) 2000 by Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033780756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033780756&partnerID=8YFLogxK

U2 - 10.1016/S0887-8994(00)00191-0

DO - 10.1016/S0887-8994(00)00191-0

M3 - Article

C2 - 11033282

AN - SCOPUS:0033780756

SN - 0887-8994

VL - 23

SP - 208

EP - 215

JO - Pediatric Neurology

JF - Pediatric Neurology

IS - 3

ER -

CAT/CLAMS: Its use in detecting early childhood cognitive impairment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this